Exponent, Menlo Park, CA, USA.
Clin Epidemiol. 2011;3:259-72. doi: 10.2147/CLEP.S23690. Epub 2011 Oct 11.
Electronic medical records (EMRs) are used increasingly for research in clinical oncology, epidemiology, and comparative effectiveness research (CER).
To assess the utility of using EMR data in population-based cancer research by comparing a database of EMRs from community oncology clinics against Surveillance Epidemiology and End Results (SEER) cancer registry data and two claims databases (Medicare and commercial claims).
DEMOGRAPHIC, CLINICAL, AND TREATMENT PATTERNS IN THE EMR, SEER, MEDICARE, AND COMMERCIAL CLAIMS DATA WERE COMPARED USING SIX TUMOR SITES: breast, lung/bronchus, head/neck, colorectal, prostate, and non-Hodgkin's lymphoma (NHL). We identified various challenges in data standardization and selection of appropriate statistical procedures. We describe the patient and clinic inclusion criteria, treatment definitions, and consideration of the administrative and clinical purposes of the EMR, registry, and claims data to address these challenges.
Sex and 10-year age distributions of patient populations for each tumor site were generally similar across the data sets. We observed several differences in racial composition and treatment patterns, and modest differences in distribution of tumor site.
Our experience with an oncology EMR database identified several factors that must be considered when using EMRs for research purposes or generalizing results to the US cancer population. These factors were related primarily to evaluation of treatment patterns, including evaluation of stage, geographic location, race, and specialization of the medical facilities. While many specialty EMRs may not provide the breadth of data on medical care, as found in comprehensive claims databases and EMR systems, they can provide detailed clinical data not found in claims that are extremely important in conducting epidemiologic and outcomes research.
电子病历(EMR)越来越多地用于临床肿瘤学、流行病学和比较效果研究(CER)的研究。
通过将社区肿瘤诊所的 EMR 数据库与监测、流行病学和最终结果(SEER)癌症登记数据以及两个索赔数据库(医疗保险和商业索赔)进行比较,评估在基于人群的癌症研究中使用 EMR 数据的效用。
使用六个肿瘤部位(乳房、肺/支气管、头/颈部、结直肠、前列腺和非霍奇金淋巴瘤(NHL))比较 EMR、SEER、医疗保险和商业索赔数据中的人口统计学、临床和治疗模式。我们发现数据标准化和选择适当统计程序方面存在各种挑战。我们描述了患者和诊所的纳入标准、治疗定义,并考虑了 EMR、登记处和索赔数据的管理和临床目的,以解决这些挑战。
每个肿瘤部位的患者人群的性别和 10 年年龄分布在数据集之间通常相似。我们观察到种族构成和治疗模式存在一些差异,肿瘤部位的分布也存在一些差异。
我们在肿瘤 EMR 数据库方面的经验确定了在出于研究目的或将结果推广到美国癌症人群时必须考虑的几个因素。这些因素主要与治疗模式的评估有关,包括评估阶段、地理位置、种族和医疗机构的专业化。虽然许多专科 EMR 可能无法提供综合索赔数据库和 EMR 系统中发现的关于医疗保健的广泛数据,但它们可以提供索赔中找不到的详细临床数据,这些数据在进行流行病学和结果研究方面非常重要。